Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-κB
Wenjuan Zhang, Zheng-Ming Fang, Wenqi Liu
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

NLRP3 and pyroptosis blockers for treating inflammatory diseases
Rebecca C. Coll, Kate Schroder, Pablo Pelegrı́n
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 653-668
Open Access | Times Cited: 417
Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation
Ling Peng, Wen Li, Qingfeng Shi, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 244
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
Sarah E. Corcoran, Reena Halai, Matthew A. Cooper
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 968-1000
Open Access | Times Cited: 116
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam, Paul Saleeb, Shyam Kottilil
Cells (2021) Vol. 10, Iss. 5, pp. 1097-1097
Open Access | Times Cited: 81
Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
Can Gan, Qiuyu Cai, Chengwei Tang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 66
Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options
Fatemeh Yarmohammadi, Hedyieh Karbasforooshan, A. Wallace Hayes, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 10, pp. 2003-2011
Closed Access | Times Cited: 45
Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis
Benedikt Kaufmann, Lin Kui, Agustina Reca, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 14, Iss. 4, pp. 751-767
Open Access | Times Cited: 32
Insights on drug and gene delivery systems in liver fibrosis
Kunj Vyas, Mayur M. Patel
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 2, pp. 100779-100779
Open Access | Times Cited: 18
Taurine Alleviates Schistosoma-Induced Liver Injury by Inhibiting the TXNIP/NLRP3 Inflammasome Signal Pathway and Pyroptosis
Xin Liu, Ya-Rong Zhang, Chen Cai, et al.
Infection and Immunity (2019) Vol. 87, Iss. 12
Open Access | Times Cited: 49
Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis
Zhiheng Zhu, Renyue Hu, Jidan Li, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107660-107660
Closed Access | Times Cited: 40
NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα(12/13)/MAPK signaling pathway
Lei Hou, Zhang Zhi, Le Yang, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 2, pp. 273-288
Closed Access | Times Cited: 36
Atorvastatin inhibited TNF-α induced matrix degradation in rat nucleus pulposus cells by suppressing NLRP3 inflammasome activity and inducing autophagy through NF-κB signaling
Jiancong Chen, Jiansen Yan, Shuangxing Li, et al.
Cell Cycle (2021) Vol. 20, Iss. 20, pp. 2160-2173
Open Access | Times Cited: 36
Punicalin Ameliorates Cell Pyroptosis Induced by LPS/ATP Through Suppression of ROS/NLRP3 Pathway
Ruiting Shen, Peng Yin, Hua Yao, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 711-718
Open Access | Times Cited: 35
The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
Carol M. Artlett
Biomolecules (2022) Vol. 12, Iss. 5, pp. 634-634
Open Access | Times Cited: 23
Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis
Zhilong Liu, Lichen Zhang, Yinming Liang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 23
Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis
Harsh Vardhan Charan, Durgesh Kumar Dwivedi, Sabbir Khan, et al.
Genes & Diseases (2022) Vol. 10, Iss. 2, pp. 480-494
Open Access | Times Cited: 22
Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy
K. Zakrzewska, Rosaria Arvia, Gloria Bua, et al.
Aspects of Molecular Medicine (2023) Vol. 1, pp. 100007-100007
Open Access | Times Cited: 15
Inhibition of Lipopolysaccharide-Induced Inflammation of Chicken Liver Tissue by Selenomethionine via TLR4-NF-κB-NLRP3 Signaling Pathway
Jingrui Qu, Wei Wang, Qiaojian Zhang, et al.
Biological Trace Element Research (2019) Vol. 195, Iss. 1, pp. 205-214
Closed Access | Times Cited: 37
Role of NLRP3 inflammasome in liver disease
Abdullah Al Mamun, Afroza Akter, Sukria Hossain, et al.
Journal of Digestive Diseases (2020) Vol. 21, Iss. 8, pp. 430-436
Open Access | Times Cited: 36
Therapeutic Effect of Diminazene Aceturate on Parasitic Blood Fluke Schistosoma mansoni Infection
Mariana Gontijo de Brito, Ana C. Mengarda, George Laylson da Silva Oliveira, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 11
Open Access | Times Cited: 33
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH
Ryan D. Welch, Cyrielle Billon, McKenna Losby, et al.
Metabolites (2022) Vol. 12, Iss. 3, pp. 238-238
Open Access | Times Cited: 21
Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation
Fernando Lucas‐Ruiz, Alejandro Peñín‐Franch, J.A. Pons, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14396-14396
Open Access | Times Cited: 21
Quercetin potentiates the hepatoprotective effect of sildenafil and/or pentoxifylline against intrahepatic cholestasis: Role of Nrf2/ARE, TLR4/NF-κB, and NLRP3/IL-1β signaling pathways
Michael Atef Fawzy, Gehad Nasr, Fares E.M. Ali, et al.
Life Sciences (2022) Vol. 314, pp. 121343-121343
Open Access | Times Cited: 21
NLRP3 inflammasome in digestive diseases: From mechanism to therapy
Rui Qiang, Yanbo Li, Xin-can Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Methane-Rich Saline Counteracts Cholestasis-Induced Liver Damage via Regulating the TLR4/NF-κB/NLRP3 Inflammasome Pathway
Zeyu Li, Dongdong Chen, Yifan Jia, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-13
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top